# Preventive Effects of Probiotic and Postbiotic Lacticaseibacillus paracasei HY2782 on DSS-induced Colitis in Mice: Comparable Efficacy of Live and Heat-Killed Forms

**Authors:** Daehyeop Lee, Hyeonjun Gwon, Ji-Woong Jeong, Joo-Yun Kim, Jae-Jung Shim, Jae-Hwan Lee

PMC · DOI: 10.4014/jmb.2512.12027 · Journal of Microbiology and Biotechnology · 2026-01-21

## TL;DR

This study shows that both live and heat-killed forms of Lacticaseibacillus paracasei HY2782 can prevent colitis in mice, suggesting they are equally effective for treating intestinal inflammation.

## Contribution

The study demonstrates that both probiotic and postbiotic forms of HY2782 are comparably effective in preventing DSS-induced colitis in mice.

## Key findings

- Both live and heat-killed HY2782 reduced disease activity and preserved colon length in DSS-induced colitis.
- HY2782 treatment suppressed pro-inflammatory cytokines and restored tight junction-related gene expression.
- Gut microbiota changes were limited and similar between live and heat-killed HY2782 forms.

## Abstract

Ulcerative colitis is chronic inflammatory bowel disease characterized by intestinal inflammation and barrier dysfunction. Probiotics and postbiotics have been proposed as dietary interventions for intestinal health; however, their comparative preventive effects remain unclear. In this study, we evaluated the preventive effects of probiotic and postbiotic forms of Lacticaseibacillus paracasei HY2782 in a dextran sulfate sodium (DSS)-induced colitis mouse model. Male C57BL/6 mice were orally administered live or heat-killed HY2782 prior to DSS exposure. Disease activity index, colon length, histopathological damage, inflammatory cytokine expression, and intestinal barrier-related gene expression were assessed, and gut microbiota composition was analyzed using 16S rRNA gene sequencing. Both probiotic and postbiotic forms of HY2782 significantly alleviated DSS-induced colitis, as evidenced by reduced disease activity, preserved colon length, improved histological features, and suppressed expression of pro-inflammatory cytokines. In addition, HY2782 treatment restored the expression of tight junction-related genes in colonic tissue. Gut microbiota analysis revealed limited but specific compositional changes following HY2782 administration, with no marked differences between live and heat-killed forms. These findings demonstrate that both probiotic and postbiotic forms of HY2782 exert preventive effects against DSS-induced colitis with no statistically significant differences between the two preparations. This suggests that HY2782 has significant potential as a versatile functional ingredient in both live and inactivated forms for the prevention of inflammatory bowel diseases, although further studies are needed to fully elucidate their distinct mechanistic roles.

## Linked entities

- **Diseases:** Ulcerative colitis (MONDO:0005101)

## Full-text entities

- **Genes:** TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Tlr4 (toll-like receptor 4) [NCBI Gene 21898] {aka Lps, Ly87, Ran/M1, Rasl2-8}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, TJP2 (tight junction protein 2) [NCBI Gene 9414] {aka C9DUPq21.11, DFNA51, DUP9q21.11, FHCA1, PFIC4, X104}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, 16S (DNA segment, 16S) [NCBI Gene 27471], IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, TJP1 (tight junction protein 1) [NCBI Gene 7082] {aka ZO-1}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, OCLN (occludin) [NCBI Gene 100506658] {aka BLCPMG, PPP1R115, PTORCH1}
- **Diseases:** fecal bleeding (MESH:D005242), drug hypersensitivity (MESH:D004342), rectal bleeding (MESH:D012002), Faith's PD (MESH:D010300), Inflammation (MESH:D007249), chronic diarrhea (MESH:D003967), chronic inflammatory diseases (MESH:D002908), gastrointestinal disorders (MESH:D005767), intestinal disorder (MESH:D007410), edema (MESH:D004487), abdominal pain (MESH:D015746), Dysbiosis (MESH:D064806), weight loss (MESH:D015431), epithelial dysfunction (MESH:D009375), nausea, vomiting (MESH:D020250), UC (MESH:D003093), microbial infections (MESH:D015163), watery diarrhea (MESH:D003969), IBD (MESH:D015212), crypt (MESH:D058739), DSS (MESH:C562576), CD (MESH:D003424), infection (MESH:D007239), Body weight loss (MESH:D001835), gastrointestinal symptoms (MESH:D012817), Colitis (MESH:D003092), mucosal erosion (MESH:D014077), mucosal damage (MESH:D052016), immune dysregulation (OMIM:614878)
- **Chemicals:** Hematoxylin (MESH:D006416), agar (MESH:D000362), CO2 (MESH:D002245), paraffin (MESH:D010232), water (MESH:D014867), LPS (MESH:D008070), streptomycin (MESH:D013307), penicillin (MESH:D010406), H&amp;E (MESH:D006371), Eosin (MESH:D004801), sulfasalazine (MESH:D012460), HY2782K (-), SCFAs (MESH:D005232), 5-ACA (MESH:D019804), formalin (MESH:D005557), DSS (MESH:D016264)
- **Species:** Homo sapiens (human, species) [taxon 9606], Muribaculum (genus) [taxon 1918540], Ligilactobacillus murinus (species) [taxon 1622], Philonthus vulgatus (species) [taxon 1896615], Faecalibaculum (genus) [taxon 1729679], Parasutterella excrementihominis (species) [taxon 487175], Enterococcus (genus) [taxon 1350], Erysipelatoclostridium [taxon 1505663], Mus musculus (house mouse, species) [taxon 10090], Phocaeicola vulgatus (species) [taxon 821], Bifidobacterium (genus) [taxon 1678], Lacticaseibacillus paracasei (species) [taxon 1597]
- **Cell lines:** Caco-2 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_0025), RAW 264.7 — Mus musculus (Mouse), Mouse leukemia, Cancer cell line (CVCL_0493), /6 — Homo sapiens (Human), Tongue squamous cell carcinoma, Cancer cell line (CVCL_5985)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12868948/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12868948/full.md

## References

50 references — full list in the complete paper: https://tomesphere.com/paper/PMC12868948/full.md

---
Source: https://tomesphere.com/paper/PMC12868948